Cooper Simon Peter — SEC Form 4 filings

SEC reporting owner CIK 1877225. 3 Form 4 filings on record with FilingPulse; latest filed 2024-08-20.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-15 to 2024-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Morphic Holding, Inc. (MORF)CMO26
Keros Therapeutics, Inc. (KROS)CHIEF MEDICAL OFFICER11

Form 4 filings — Cooper Simon Peter

FiledFormIssuerReported transactionsSource
2024-08-204Morphic Holding, Inc. (MORF)Disposition to issuer (D): 170,000 (derivative) · Disposition to issuer (D): 14,000 (derivative) · Disposition to issuer (D): 7,000 (derivative)EDGAR
2024-03-194Morphic Holding, Inc. (MORF)Grant/award (A): 170,000 (derivative) @ $0 · Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0EDGAR
2024-02-154Keros Therapeutics, Inc. (KROS)Grant/award (A): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1877225 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →